It is announced that the Merck & Co. antiviral drug molnupiravir will be available to Philippine patients after an agreement was signed between the Office of the Vice President of the Philippines and a local health care provider after the Food and Drug Administration gave a compassionate special permit for the drug.
It is announced that Merck & Co.'s antiviral drug molnupiravir will be available to Philippine patients after aftertheFoodandDrugAdministrationissuedacompassionatespecialpermitforthedrugandanagreement was signed between the Office of the Vice President of the Philippines and a local health care provider.
It is announced that Merck & Co.'s antiviral drug molnupiravir will be available to Philippine patients after the Food and Drug Administration issued a compassionate special permit for the drug and an agreement was signed between the Office of the Vice President of the Philippines and a local health care provider.